JP2009533341A - 抗細菌、抗真菌、抗酵母、および／または抗ウイルス特性を有するナノ構造組成物 - Google Patents

抗細菌、抗真菌、抗酵母、および／または抗ウイルス特性を有するナノ構造組成物 Download PDF

Info

Publication number
JP2009533341A
JP2009533341A JP2009504226A JP2009504226A JP2009533341A JP 2009533341 A JP2009533341 A JP 2009533341A JP 2009504226 A JP2009504226 A JP 2009504226A JP 2009504226 A JP2009504226 A JP 2009504226A JP 2009533341 A JP2009533341 A JP 2009533341A
Authority
JP
Japan
Prior art keywords
less
oil
active agent
composition
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009504226A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009533341A5 (cg-RX-API-DMAC10.html
Inventor
シェノイ，ディネッシュ
リー，ロバート
ライト，クレイグ
Original Assignee
ノババックス，インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ノババックス，インコーポレイテッド filed Critical ノババックス，インコーポレイテッド
Publication of JP2009533341A publication Critical patent/JP2009533341A/ja
Publication of JP2009533341A5 publication Critical patent/JP2009533341A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
    • A01N25/04—Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/02—Acyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Agronomy & Crop Science (AREA)
  • Dispersion Chemistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2009504226A 2006-04-07 2007-04-03 抗細菌、抗真菌、抗酵母、および／または抗ウイルス特性を有するナノ構造組成物 Pending JP2009533341A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78991706P 2006-04-07 2006-04-07
PCT/US2007/008054 WO2007123790A1 (en) 2006-04-07 2007-04-03 Nanostructured compositions having antibacterial, anti-fungal, anti-yeast, and/or anti-viral properties

Publications (2)

Publication Number Publication Date
JP2009533341A true JP2009533341A (ja) 2009-09-17
JP2009533341A5 JP2009533341A5 (cg-RX-API-DMAC10.html) 2010-04-30

Family

ID=38436994

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009504226A Pending JP2009533341A (ja) 2006-04-07 2007-04-03 抗細菌、抗真菌、抗酵母、および／または抗ウイルス特性を有するナノ構造組成物

Country Status (6)

Country Link
EP (1) EP2010149A1 (cg-RX-API-DMAC10.html)
JP (1) JP2009533341A (cg-RX-API-DMAC10.html)
CN (1) CN101466355A (cg-RX-API-DMAC10.html)
AU (1) AU2007240983A1 (cg-RX-API-DMAC10.html)
CA (1) CA2648360A1 (cg-RX-API-DMAC10.html)
WO (1) WO2007123790A1 (cg-RX-API-DMAC10.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016510330A (ja) * 2013-01-25 2016-04-07 ケミラ ユルキネン オサケイティエＫｅｍｉｒａ Ｏｙｊ 殺生物剤組成物及び水の処理方法
JP2018532770A (ja) * 2015-09-17 2018-11-08 アラヤ （シャンハイ） バイオサイエンス カンパニー リミテッド 高安定性の非小胞型ナノ粒子および微生物感染の治療におけるその使用

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009504805A (ja) 2005-08-09 2009-02-05 ナノバイオ コーポレーション 抗炎症活性を有するナノエマルジョン組成物
WO2008039864A1 (en) * 2006-09-26 2008-04-03 Novavax, Inc. Emulsion formulations for transdermal delivery of poorly water soluble active agents
US9981069B2 (en) 2007-06-20 2018-05-29 The Trustees Of Columbia University In The City Of New York Bio-film resistant surfaces
US9511040B2 (en) 2007-06-20 2016-12-06 The Trustees Of Columbia University In The City Of New York Skin and surface disinfectant compositions containing botanicals
WO2008157092A1 (en) 2007-06-20 2008-12-24 The Trustees Of Columbia University In The City Of New York Bio-film resistant surfaces
US9687429B2 (en) 2007-06-20 2017-06-27 The Trustees Of Columbia University In The City Of New York Antimicrobial compositions containing low concentrations of botanicals
US9078864B2 (en) 2008-01-08 2015-07-14 Akthelia Pharmaceuticals Agonists for antimicrobial peptide systems
MX2012000105A (es) * 2009-06-30 2012-03-14 Univ Columbia Composiciones antimicrobianas/conservadoras que comprenden extractos botanicos.
AU2012332495B2 (en) 2011-11-03 2017-06-08 The Trustees Of Columbia University In The City Of New York Composition with sustained antimicrobial activity
US9968101B2 (en) 2011-11-03 2018-05-15 The Trustees Of Columbia University In The City Of New York Botanical antimicrobial compositions
EP2782584B1 (en) 2011-11-23 2021-06-09 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
WO2013086094A1 (en) 2011-12-06 2013-06-13 The Trustees Of Columbia University In The City Of New York Broad spectrum natural preservative composition
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
FR2997304B1 (fr) * 2012-10-26 2017-07-07 Isp Investments Inc Utilisation d’un extrait de lin, en tant qu’agent actif activateur de la synthese de peptides antimicrobiens
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AR100562A1 (es) 2014-05-22 2016-10-12 Therapeuticsmd Inc Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
KR20170040209A (ko) 2014-07-29 2017-04-12 쎄러퓨틱스엠디, 인코퍼레이티드 경피 크림
CA2990941C (en) * 2015-07-01 2024-02-20 Nissim Garti Delivery systems for propofol
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
CN105241793B (zh) * 2015-09-07 2016-10-26 国家纳米科学中心 一种载药胶束形态粒径的测定方法
CN107949389A (zh) * 2015-09-30 2018-04-20 富士胶片株式会社 经皮吸收用组合物
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
CN113728865B (zh) * 2021-09-24 2022-12-13 广西壮族自治区亚热带作物研究所（广西亚热带农产品加工研究所） 一种澳洲坚果促花保果的综合管理方法
BE1030538B1 (nl) * 2022-05-18 2023-12-19 Bogaert Gina Van Liposomaal preparaat met ingekapselde hormonen, werkwijze voor de productie en gebruik ervan
WO2025054263A2 (en) * 2023-09-06 2025-03-13 The Board Of Regents Of The University Of Texas System Compositions and methods of ent-testosterone for treatment of bacterial infections

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10513185A (ja) * 1995-01-31 1998-12-15 ノババックス インコーポレイテッド ミセル性ナノ粒子
JP2005514325A (ja) * 2001-06-25 2005-05-19 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 抗微生物ナノエマルジョンの組成物および方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767216B2 (en) * 1999-04-28 2010-08-03 The Regents Of The University Of Michigan Antimicrobial compositions and methods of use
EP1633322A2 (en) * 2003-06-04 2006-03-15 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
US20050208083A1 (en) * 2003-06-04 2005-09-22 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10513185A (ja) * 1995-01-31 1998-12-15 ノババックス インコーポレイテッド ミセル性ナノ粒子
JP2005514325A (ja) * 2001-06-25 2005-05-19 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 抗微生物ナノエマルジョンの組成物および方法

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016510330A (ja) * 2013-01-25 2016-04-07 ケミラ ユルキネン オサケイティエＫｅｍｉｒａ Ｏｙｊ 殺生物剤組成物及び水の処理方法
JP2018532770A (ja) * 2015-09-17 2018-11-08 アラヤ （シャンハイ） バイオサイエンス カンパニー リミテッド 高安定性の非小胞型ナノ粒子および微生物感染の治療におけるその使用
US11266604B2 (en) 2015-09-17 2022-03-08 Alaya (Shanghai) Bioscience Co., Ltd. Highly stable non-vesicular nanoparticles and application thereof in treating microbial infection
JP7048496B2 (ja) 2015-09-17 2022-04-05 アラヤ （シャンハイ） バイオサイエンス カンパニー リミテッド 高安定性の非小胞型ナノ粒子および微生物感染の治療におけるその使用

Also Published As

Publication number Publication date
AU2007240983A1 (en) 2007-11-01
CA2648360A1 (en) 2007-11-01
WO2007123790A1 (en) 2007-11-01
CN101466355A (zh) 2009-06-24
EP2010149A1 (en) 2009-01-07

Similar Documents

Publication Publication Date Title
AU2007240983A1 (en) Nanostructured compositions having antibacterial, anti-fungal, anti-yeast, and/or anti-viral properties
Garcia et al. Nanoemulsion delivery systems for enhanced efficacy of antimicrobials and essential oils
Pavoni et al. Microemulsions: An effective encapsulation tool to enhance the antimicrobial activity of selected EOs
US20070264349A1 (en) Nano-structured compositions and methods of making and using the same
Bajerski et al. The use of Brazilian vegetable oils in nanoemulsions: an update on preparation and biological applications
AU2005201276B2 (en) Antimicrobial nanoemulsion compositions and methods
US6559189B2 (en) Non-toxic antimicrobial compositions and methods of use
US8232320B2 (en) Antimicrobial nanoemulsion compositions and methods
US20040043041A1 (en) Antimicrobial compositions and methods of use
Rajpoot et al. Therapeutic applications of nanoemulsion based drug delivery systems: a review of patents in last two decades
US20240065998A1 (en) Monoacylglycerol and free fatty acid-based compositions, methods of manufacturing and use of the same
Abolmaali et al. Pharmaceutical Nanoemulsions and Their Potential Topical and Transdermal Applications: Pharmaceutical nanoemulsions potential applications
US20110262499A1 (en) Topical herbal formulation for treatment of acne and skin disorders
US20240082118A1 (en) Topical compositions and methods of preparing the same
CN101516358A (zh) 抗病毒组合物以及它们的使用
CN106727324B (zh) 纳米银脂质体及其制备方法和应用
CN101484138A (zh) 难溶性药用活性成分的纳米乳液和制备该乳液的方法
CN102166188A (zh) 一种水包油型樟脑油纳米乳制剂及其制备方法
AU2023270264B2 (en) Topical compositions and methods of preparing the same
WO2005030172A1 (en) Antimicrobial nanoemulsion compositions and methods
JP2026506823A (ja) プロポリス抽出物のナノ構造水性製剤およびその使用
WO2024013694A1 (en) Compositions comprising surface modified globular nano-particles
JP2007106674A (ja) マンゴスチン製剤
US20250144039A1 (en) Compositions comprising surface modified globular nano-particles
JP2010209109A (ja) 抗微生物ナノエマルジョンの組成物および方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100310

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100310

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120627

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20120629

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20121116